HR 2498 EAS
is situated) of the facility as the amount of the Federal par-
ticipation bore to the cost of the construction of such facil-
ity.
‘‘(g) GUIDELINES.—Not later than 6 months after the
date of the enactment of this section, the Director of the
Center, after consultation with the Advisory Council, shall
issue guidelines with respect to grants under subsection (a).
‘‘(h) REPORT TO CONGRESS.—The Director of the Cen-
ter shall prepare and submit to the appropriate committees
of Congress a biennial report concerning the status of the
biomedical and behavioral research facilities and the avail-
ability and condition of technologically sophisticated lab-
oratory equipment in the United States. Such reports shall
be developed in concert with the report prepared by the Na-
tional Science Foundation on the needs of research facilities
of universities as required under section 108 of the National
Science Foundation Authorization Act for Fiscal Year 1986
(42 U.S.C. 1886).
‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—For the
purpose of carrying out this section, there are authorized
to be appropriated $250,000,000 for fiscal year 2001, and
such sums as may be necessary for each of the fiscal years
2002 and 2003.’’.
HR 2498 EAS
SEC. 304. CONSTRUCTION PROGRAM FOR NATIONAL PRI-
MATE RESEARCH CENTERS.
Section 481B(a) of the Public Health Service Act (42
U.S.C. 287a–3(a)) is amended by striking ‘‘1994’’ and all
that follows through ‘‘$5,000,000’’ and inserting ‘‘2000
through 2002, reserve from the amounts appropriated under
section 481A(i) such sums as necessary’’.
SEC. 305. SHARED INSTRUMENTATION GRANT PROGRAM.
(a) AUTHORIZATION OF APPROPRIATIONS.—There is
authorized to be appropriated $100,000,000 for fiscal year
2000, and such sums as may be necessary for each subse-
quent fiscal year, to enable the Secretary of Health and
Human Services, acting through the Director of the Na-
tional Center for Research Resources, to provide for the con-
tinued operation of the Shared Instrumentation Grant Pro-
gram (initiated in fiscal year 1992 under the authority of
section 479 of the Public Health Service Act (42 U.S.C. 287
et seq.)).
(b) REQUIREMENTS
FOR GRANTS.—In determining
whether to award a grant to an applicant under the pro-
gram described in subsection (a), the Director of the Na-
tional Center for Research Resources shall consider—
(1) the extent to which an award for the specific
instrument involved would meet the scientific needs
and enhance the planned research endeavors of the
HR 2498 EAS
major users by providing an instrument that is un-
available or to which availability is highly limited;
(2) with respect to the instrument involved, the
availability and commitment of the appropriate tech-
nical expertise within the major user group or the ap-
plicant institution for use of the instrumentation;
(3) the adequacy of the organizational plan for
the use of the instrument involved and the internal
advisory committee for oversight of the applicant, in-
cluding sharing arrangements if any;
(4) the applicant’s commitment for continued
support of the utilization and maintenance of the in-
strument; and
(5) the extent to which the specified instrument
will be shared and the benefit of the proposed instru-
ment to the overall research community to be served.
(c) PEER REVIEW.—In awarding grants under the
program described in subsection (a) Director of the Na-
tional Center for Research Resources shall comply with the
peer review requirements in section 492 of the Public
Health Service Act (42 U.S.C. 289a).
HR 2498 EAS
TITLE IV—CARDIAC ARREST
SURVIVAL
Subtitle A—Recommendations for
Federal Buildings
SEC. 401. SHORT TITLE.
This subtitle may be cited as the ‘‘Cardiac Arrest Sur-
vival Act of 2000’’.
SEC. 402. FINDINGS.
Congress makes the following findings:
(1) Over 700 lives are lost every day to sudden
cardiac arrest in the United States alone.
(2) Two out of every three sudden cardiac deaths
occur before a victim can reach a hospital.
(3) More than 95 percent of these cardiac arrest
victims will die, many because of lack of readily
available life saving medical equipment.
(4) With current medical technology, up to 30
percent of cardiac arrest victims could be saved if vic-
tims had access to immediate medical response, in-
cluding defibrillation and cardiopulmonary resuscita-
tion.
(5) Once a victim has suffered a cardiac arrest,
every minute that passes before returning the heart to
a normal rhythm decreases the chance of survival by
10 percent.
HR 2498 EAS
(6) Most cardiac arrests are caused by abnormal
heart rhythms called ventricular fibrillation. Ventric-
ular fibrillation occurs when the heart’s electrical sys-
tem malfunctions, causing a chaotic rhythm that pre-
vents the heart from pumping oxygen to the victim’s
brain and body.
(7) Communities that have implemented pro-
grams 
ensuring 
widespread 
public 
access 
to
defibrillators, combined with appropriate training,
maintenance, and coordination with local emergency
medical systems, have dramatically improved the sur-
vival rates from cardiac arrest.
(8) Automated external defibrillator devices have
been demonstrated to be safe and effective, even when
used by lay people, since the devices are designed not
to allow a user to administer a shock until after the
device has analyzed a victim’s heart rhythm and de-
termined that an electric shock is required.
(9) Increasing public awareness regarding auto-
mated external defibrillator devices and encouraging
their use in Federal buildings will greatly facilitate
their adoption.
(10) Limiting the liability of Good Samaritans
and acquirers of automated external defibrillator de-
vices in emergency situations may encourage the use
HR 2498 EAS
of automated external defibrillator devices, and result
in saved lives.
SEC. 403. RECOMMENDATIONS AND GUIDELINES OF SEC-
RETARY OF HEALTH AND HUMAN SERVICES
REGARDING 
AUTOMATED 
EXTERNAL
DEFIBRILLATORS FOR FEDERAL BUILDINGS.
Part B of title II of the Public Health Service Act (42
U.S.C. 238 et seq.) is amended by adding at the end the
following:
‘‘RECOMMENDATIONS AND GUIDELINES REGARDING AUTO-
MATED
EXTERNAL
DEFIBRILLATORS
FOR
FEDERAL
BUILDINGS
‘‘SEC. 247. (a) GUIDELINES ON PLACEMENT.—The
Secretary shall establish guidelines with respect to placing
automated external defibrillator devices in Federal build-
ings. Such guidelines shall take into account the extent to
which such devices may be used by lay persons, the typical
number of employees and visitors in the buildings, the ex-
tent of the need for security measures regarding the build-
ings, buildings or portions of buildings in which there are
special circumstances such as high electrical voltage or ex-
treme heat or cold, and such other factors as the Secretary
determines to be appropriate.
‘‘(b) RELATED RECOMMENDATIONS.—The Secretary
shall publish in the Federal Register the recommendations
of the Secretary on the appropriate implementation of the
HR 2498 EAS
placement of automated external defibrillator devices under
subsection (a), including procedures for the following:
‘‘(1) Implementing appropriate training courses
in the use of such devices, including the role of
cardiopulmonary resuscitation.
‘‘(2) Proper maintenance and testing of the de-
vices.
‘‘(3) Ensuring coordination with appropriate li-
censed professionals in the oversight of training of the
devices.
‘‘(4) Ensuring coordination with local emergency
medical systems regarding the placement and inci-
dents of use of the devices.
‘‘(c) CONSULTATIONS; CONSIDERATION
OF CERTAIN
RECOMMENDATIONS.—In carrying out this section, the Sec-
retary shall—
‘‘(1) consult with appropriate public and private
entities;
‘‘(2) consider the recommendations of national
and local public-health organizations for improving
the survival rates of individuals who experience car-
diac arrest in nonhospital settings by minimizing the
time elapsing between the onset of cardiac arrest and
the initial medical response, including defibrillation
as necessary; and
HR 2498 EAS
‘‘(3) consult with and counsel other Federal
agencies where such devices are to be used.
‘‘(d) DATE CERTAIN FOR ESTABLISHING GUIDELINES
AND RECOMMENDATIONS.—The Secretary shall comply
with this section not later than 180 days after the date of
the enactment of the Cardiac Arrest Survival Act of 2000.
‘‘(e) DEFINITIONS.—For purposes of this section:
‘‘(1) The term ‘automated external defibrillator
device’ has the meaning given such term in section
248.
‘‘(2) The term ‘Federal building’ includes a
building or portion of a building leased or rented by
a Federal agency, and includes buildings on military
installations of the United States.’’.
SEC. 404. GOOD SAMARITAN PROTECTIONS REGARDING
EMERGENCY USE OF AUTOMATED EXTERNAL
DEFIBRILLATORS.
Part B of title II of the Public Health Service Act,
as amended by section 403, is amended by adding at the
end the following:
‘‘LIABILITY REGARDING EMERGENCY USE OF AUTOMATED
EXTERNAL DEFIBRILLATORS
‘‘SEC. 248. (a) GOOD SAMARITAN PROTECTIONS RE-
GARDING AEDS.—Except as provided in subsection (b),
any person who uses or attempts to use an automated exter-
nal defibrillator device on a victim of a perceived medical
HR 2498 EAS
emergency is immune from civil liability for any harm re-
sulting from the use or attempted use of such device; and
in addition, any person who acquired the device is immune
from such liability, if the harm was not due to the failure
of such acquirer of the device—
‘‘(1) to notify local emergency response personnel
or other appropriate entities of the most recent place-
ment of the device within a reasonable period of time
after the device was placed;
‘‘(2) to properly maintain and test the device; or
‘‘(3) to provide appropriate training in the use
of the device to an employee or agent of the acquirer
when the employee or agent was the person who used
the device on the victim, except that such requirement
of training does not apply if—
‘‘(A) the employee or agent was not an em-
ployee or agent who would have been reasonably
expected to use the device; or
‘‘(B) the period of time elapsing between the
engagement of the person as an employee or
agent and the occurrence of the harm (or between
the acquisition of the device and the occurrence
of the harm, in any case in which the device was
acquired after such engagement of the person)
HR 2498 EAS
was not a reasonably sufficient period in which
to provide the training.
‘‘(b) INAPPLICABILITY
OF
IMMUNITY.—Immunity
under subsection (a) does not apply to a person if—
‘‘(1) the harm involved was caused by willful or
criminal misconduct, gross negligence, reckless mis-
conduct, or a conscious, flagrant indifference to the
rights or safety of the victim who was harmed; or
‘‘(2) the person is a licensed or certified health
professional 
who 
used 
the 
automated 
external
defibrillator device while acting within the scope of
the license or certification of the professional and
within the scope of the employment or agency of the
professional; or
‘‘(3) the person is a hospital, clinic, or other en-
tity whose purpose is providing health care directly
to patients, and the harm was caused by an employee
or agent of the entity who used the device while acting
within the scope of the employment or agency of the
employee or agent; or
‘‘(4) the person is an acquirer of the device who
leased the device to a health care entity (or who other-
wise provided the device to such entity for compensa-
tion without selling the device to the entity), and the
harm was caused by an employee or agent of the enti-
HR 2498 EAS
ty who used the device while acting within the scope
of the employment or agency of the employee or agent.
‘‘(c) RULES OF CONSTRUCTION.—
‘‘(1) IN GENERAL.—The following applies with
respect to this section:
‘‘(A) This section does not establish any
cause of action, or require that an automated ex-
ternal defibrillator device be placed at any build-
ing or other location.
‘‘(B) With respect to a class of persons for
which this section provides immunity from civil
liability, this section supersedes the law of a
State only to the extent that the State has no
statute or regulations that provide persons in
such class with immunity for civil liability aris-
ing from the use by such persons of automated
external defibrillator devices in emergency situa-
tions (within the meaning of the State law or
regulation involved).
‘‘(C) This section does not waive any pro-
tection from liability for Federal officers or em-
ployees under—
‘‘(i) section 224; or
‘‘(ii) sections 1346(b), 2672, and 2679
of title 28, United States Code, or under al-
HR 2498 EAS
ternative benefits provided by the United
States where the availability of such benefits
precludes a remedy under section 1346(b) of
title 28.
‘‘(2) CIVIL ACTIONS UNDER FEDERAL LAW.—
‘‘(A) IN
GENERAL.—The applicability of
subsections (a) and (b) includes applicability to
any action for civil liability described in sub-
section (a) that arises under Federal law.
‘‘(B) FEDERAL
AREAS
ADOPTING
STATE
LAW.—If a geographic area is under Federal ju-
risdiction and is located within a State but out
of the jurisdiction of the State, and if, pursuant
to Federal law, the law of the State applies in
such area regarding matters for which there is
no applicable Federal law, then an action for
civil liability described in subsection (a) that in
such area arises under the law of the State is
subject to subsections (a) through (c) in lieu of
any related State law that would apply in such
area in the absence of this subparagraph.
‘‘(d) FEDERAL JURISDICTION.—In any civil action
arising under State law, the courts of the State involved
have jurisdiction to apply the provisions of this section ex-
clusive of the jurisdiction of the courts of the United States.
HR 2498 EAS
‘‘(e) DEFINITIONS.—
‘‘(1) PERCEIVED
MEDICAL
EMERGENCY.—For
purposes of this section, the term ‘perceived medical
emergency’ means circumstances in which the behav-
ior of an individual leads a reasonable person to be-
lieve that the individual is experiencing a life-threat-
ening medical condition that requires an immediate
medical response regarding the heart or other
cardiopulmonary functioning of the individual.
‘‘(2) OTHER DEFINITIONS.—For purposes of this
section:
‘‘(A) 
The 
term 
‘automated 
external
defibrillator device’ means a defibrillator device
that—
‘‘(i) is commercially distributed in ac-
cordance with the Federal Food, Drug, and
Cosmetic Act;
‘‘(ii) is capable of recognizing the pres-
ence or absence of ventricular fibrillation,
and is capable of determining without
intervention by the user of the device wheth-
er defibrillation should be performed;
‘‘(iii) 
upon 
determining 
that
defibrillation should be performed, is able to
HR 2498 EAS
deliver an electrical shock to an individual;
and
‘‘(iv) in the case of a defibrillator de-
vice that may be operated in either an auto-
mated or a manual mode, is set to operate
in the automated mode.
‘‘(B)(i) The term ‘harm’ includes physical,
nonphysical, economic, and noneconomic losses.
‘‘(ii) The term ‘economic loss’ means any
pecuniary loss resulting from harm (including
the loss of earnings or other benefits related to
employment, medical expense loss, replacement
services loss, loss due to death, burial costs, and
loss of business or employment opportunities) to
the extent recovery for such loss is allowed under
applicable State law.
‘‘(iii) The term ‘noneconomic losses’ means
losses for physical and emotional pain, suffering,
inconvenience, physical impairment, mental an-
guish, disfigurement, loss of enjoyment of life,
loss of society and companionship, loss of consor-
tium (other than loss of domestic service), he-
donic damages, injury to reputation and all
other nonpecuniary losses of any kind or na-
ture.’’.
HR 2498 EAS
Subtitle B—Rural Access to
Emergency Devices
SEC. 411. SHORT TITLE.
This subtitle may be cited as the ‘‘Rural Access to
Emergency Devices Act’’ or the ‘‘Rural AED Act’’.
SEC. 412. FINDINGS.
Congress makes the following findings:
(1) Heart disease is the leading cause of death in
the United States.
(2) The American Heart Association estimates
that 250,000 Americans die from sudden cardiac ar-
rest each year.
(3) A cardiac arrest victim’s chance of survival
drops 10 percent for every minute that passes before
his or her heart is returned to normal rhythm.
(4) Because most cardiac arrest victims are ini-
tially in ventricular fibrillation, and the only treat-
ment for ventricular fibrillation is defibrillation,
prompt access to defibrillation to return the heart to
normal rhythm is essential.
(5) Lifesaving technology, the automated external
defibrillator, has been developed to allow trained lay
rescuers to respond to cardiac arrest by using this
simple device to shock the heart into normal rhythm.
HR 2498 EAS
(6) Those people who are likely to be first on the
scene of a cardiac arrest situation in many commu-
nities, particularly smaller and rural communities,
lack 
sufficient 
numbers 
of 
automated 
external
defibrillators to respond to cardiac arrest in a timely
manner.
(7) The American Heart Association estimates
that more than 50,000 deaths could be prevented each
year if defibrillators were more widely available to
designated responders.
(8) Legislation should be enacted to encourage
greater 
public 
access 
to 
automated 
external
defibrillators in communities across the United
States.
SEC. 413. GRANTS.
(a) IN GENERAL.—The Secretary of Health and
Human Services, acting through the Rural Health Outreach
Office of the Health Resources and Services Administration,
shall award grants to community partnerships that meet
the requirements of subsection (b) to enable such partner-
ships to purchase equipment and provide training as pro-
vided for in subsection (c).
(b) COMMUNITY PARTNERSHIPS.—A community part-
nership meets the requirements of this subsection if such
partnership—
HR 2498 EAS
(1) is composed of local emergency response enti-
ties such as community training facilities, local emer-
gency responders, fire and rescue departments, police,
community hospitals, and local non-profit entities
and for-profit entities concerned about cardiac arrest
survival rates;
(2) evaluates the local community emergency re-
sponse times to assess whether they meet the standards
established by national public health organizations
such as the American Heart Association and the
American Red Cross; and
(3) submits to the Secretary of Health and
Human Services an application at such time, in such
manner, and containing such information as the Sec-
retary may require.
(c) USE OF FUNDS.—Amounts provided under a grant
under this section shall be used—
(1) to purchase automated external defibrillators
that have been approved, or cleared for marketing, by
the Food and Drug Administration; and
(2) to provide defibrillator and basic life support
training in automated external defibrillator usage
through the American Heart Association, the Amer-
ican Red Cross, or other nationally recognized train-
ing courses.
HR 2498 EAS
(d) REPORT.—Not later than 4 years after the date
of enactment of this Act, the Secretary of Health and
Human Services shall prepare and submit to the appro-
priate committees of Congress a report containing data re-
lating to whether the increased availability of defibrillators
has affected survival rates in the communities in which
grantees under this section operated. The procedures under
which the Secretary obtains data and prepares the report
under this subsection shall not impose an undue burden on
program participants under this section.
(e) AUTHORIZATION OF APPROPRIATIONS.—There is
authorized to be appropriated $25,000,000 for fiscal years
2001 through 2003 to carry out this section.
TITLE V—LUPUS RESEARCH AND
CARE
SEC. 501. SHORT TITLE.
This title may be cited as the ‘‘Lupus Research and
Care Amendments of 2000’’.
SEC. 502. FINDINGS.
The Congress finds that—
(1) lupus is a serious, complex, inflammatory,
autoimmune disease of particular concern to women;
(2) lupus affects women nine times more often
than men;
HR 2498 EAS
(9) many victims of the disease suffer debili-
tating pain and fatigue, making it difficult to main-
tain employment and lead normal lives; and
(10) in fiscal year 1996, the amount allocated by
the National Institutes of Health for research on
lupus was $33,000,000, which is less than one-half of
1 percent of the budget for such Institutes.
Subtitle A—Research on Lupus
SEC. 511. EXPANSION AND INTENSIFICATION OF ACTIVI-
TIES.
Subpart 4 of part C of title IV of the Public Health
Service Act (42 U.S.C. 285d et seq.) is amended by insert-
ing after section 441 the following:
‘‘LUPUS
‘‘SEC. 441A. (a) IN GENERAL.—The Director of the In-
stitute shall expand and intensify research and related ac-
tivities of the Institute with respect to lupus.
‘‘(b) COORDINATION WITH OTHER INSTITUTES.—The
Director of the Institute shall coordinate the activities of
the Director under subsection (a) with similar activities
conducted by the other national research institutes and
agencies of the National Institutes of Health to the extent
that such Institutes and agencies have responsibilities that
are related to lupus.
‘‘(c) PROGRAMS FOR LUPUS.—In carrying out sub-
section (a), the Director of the Institute shall conduct or
HR 2498 EAS
support research to expand the understanding of the causes
of, and to find a cure for, lupus. Activities under such sub-
section shall include conducting and supporting the fol-
lowing:
‘‘(1) Research to determine the reasons under-
lying the elevated prevalence of lupus in women, in-
cluding African-American women.
‘‘(2) Basic research concerning the etiology and
causes of the disease.
‘‘(3) Epidemiological studies to address the fre-
quency and natural history of the disease and the dif-
ferences among the sexes and among racial and ethnic
groups with respect to the disease.
‘‘(4) The development of improved diagnostic
techniques.
‘‘(5) Clinical research for the development and
evaluation of new treatments, including new biologi-
cal agents.
‘‘(6) Information and education programs for
health care professionals and the public.
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the
purpose of carrying out this section, there are authorized
to be appropriated such sums as may be necessary for each
of the fiscal years 2001 through 2003.’’.
HR 2498 EAS
Subtitle B—Delivery of Services
Regarding Lupus
SEC. 521. ESTABLISHMENT OF PROGRAM OF GRANTS.
(a) IN GENERAL.—The Secretary of Health and
Human Services shall in accordance with this subtitle make
grants to provide for projects for the establishment, oper-
ation, and coordination of effective and cost-efficient sys-
tems for the delivery of essential services to individuals with
lupus and their families.
(b) RECIPIENTS OF GRANTS.—A grant under sub-
section (a) may be made to an entity only if the entity
is a public or nonprofit private entity, which may include
a State or local government; a public or nonprofit private
hospital, community-based organization, hospice, ambula-
tory care facility, community health center, migrant health
center, or homeless health center; or other appropriate pub-
lic or nonprofit private entity.
(c) CERTAIN ACTIVITIES.—To the extent practicable
and appropriate, the Secretary shall ensure that projects
under subsection (a) provide services for the diagnosis and
disease management of lupus. Activities that the Secretary
may authorize for such projects may also include the fol-
lowing:
(1) Delivering or enhancing outpatient, ambula-
tory, and home-based health and support services, in-
HR 2498 EAS
cluding case management and comprehensive treat-
ment services, for individuals with lupus; and deliv-
ering or enhancing support services for their families.
(2) Delivering or enhancing inpatient care man-
agement services that prevent unnecessary hos-
pitalization or that expedite discharge, as medically
appropriate, from inpatient facilities of individuals
with lupus.
(3) Improving the quality, availability, and or-
ganization of health care and support services (in-
cluding transportation services, attendant care, home-
maker services, day or respite care, and providing
counseling on financial assistance and insurance) for
individuals with lupus and support services for their
families.
(d) INTEGRATION WITH OTHER PROGRAMS.—To the
extent practicable and appropriate, the Secretary shall inte-
grate the program under this subtitle with other grant pro-
grams carried out by the Secretary, including the program
under section 330 of the Public Health Service Act.
SEC. 522. CERTAIN REQUIREMENTS.
A grant may be made under section 521 only if the
applicant involved makes the following agreements:
HR 2498 EAS
(1) Not more than 5 percent of the grant will be
used for administration, accounting, reporting, and
program oversight functions.
(2) The grant will be used to supplement and not
supplant funds from other sources related to the treat-
ment of lupus.
(3) The applicant will abide by any limitations
deemed appropriate by the Secretary on any charges
to individuals receiving services pursuant to the
grant. As deemed appropriate by the Secretary, such
limitations on charges may vary based on the finan-
cial circumstances of the individual receiving services.
(4) The grant will not be expended to make pay-
ment for services authorized under section 521(a) to
the extent that payment has been made, or can rea-
sonably be expected to be made, with respect to such
services—
(A) under any State compensation pro-
gram, under an insurance policy, or under any
Federal or State health benefits program; or
(B) by an entity that provides health serv-
ices on a prepaid basis.
(5) The applicant will, at each site at which the
applicant provides services under section 521(a), post
a conspicuous notice informing individuals who re-
HR 2498 EAS
ceive the services of any Federal policies that apply
to the applicant with respect to the imposition of
charges on such individuals.
SEC. 523. TECHNICAL ASSISTANCE.
The Secretary may provide technical assistance to as-
sist entities in complying with the requirements of this sub-
title in order to make such entities eligible to receive grants
under section 521.
SEC. 524. DEFINITIONS.
For purposes of this subtitle:
(1) OFFICIAL POVERTY LINE.—The term ‘‘official
poverty line’’ means the poverty line established by
the Director of the Office of Management and Budget
and revised by the Secretary in accordance with sec-
tion 673(2) of the Omnibus Budget Reconciliation Act
of 1981.
(2) SECRETARYThe term ‘‘Secretary’’ means the
Secretary of Health and Human Services.
SEC. 525. AUTHORIZATION OF APPROPRIATIONS.
For the purpose of carrying out this subtitle, there are
authorized to be appropriated such sums as may be nec-
essary for each of the fiscal years 2001 through 2003.
HR 2498 EAS
TITLE VI—PROSTATE CANCER
RESEARCH AND PREVENTION
SEC. 601. SHORT TITLE.
This title may be cited as the ‘‘Prostate Cancer Re-
search and Prevention Act’’.
SEC. 602. AMENDMENTS TO THE PUBLIC HEALTH SERVICE
ACT.
(a) PREVENTIVE HEALTH MEASURES.—Section 317D
of the Public Health Service Act (42 U.S.C. 247b–5) is
amended—
(1) by striking subsection (a) and inserting the
following:
‘‘(a) IN GENERAL.—The Secretary, acting through the
Director of the Centers for Disease Control and Prevention,
may make grants to States and local health departments
for the purpose of enabling such States and departments
to carry out programs that may include the following:
‘‘(1) To identify factors that influence the atti-
tudes or levels of awareness of men and health care
practitioners regarding screening for prostate cancer.
‘‘(2) To evaluate, in consultation with the Agen-
cy for Health Care Policy and Research and the Na-
tional Institutes of Health, the effectiveness of screen-
ing strategies for prostate cancer.
HR 2498 EAS
‘‘(3) To identify, in consultation with the Agency
for Health Care Policy and Research, issues related to
the quality of life for men after prostrate cancer
screening and followup.
‘‘(4) To develop and disseminate public informa-
tion and education programs for prostate cancer, in-
cluding appropriate messages about the risks and ben-
efits of prostate cancer screening for the general pub-
lic, health care providers, policy makers and other ap-
propriate individuals.
‘‘(5) To improve surveillance for prostate cancer.
‘‘(6) To address the needs of underserved and mi-
nority populations regarding prostate cancer.
‘‘(7) Upon a determination by the Secretary,
who shall take into consideration recommendations by
the United States Preventive Services Task Force and
shall seek input, where appropriate, from professional
societies and other private and public entities, that
there is sufficient consensus on the effectiveness of
prostate cancer screening—
‘‘(A) to screen men for prostate cancer as a
preventive health measure;
‘‘(B) to provide appropriate referrals for the
medical treatment of men who have been
screened under subparagraph (A) and to ensure,
HR 2498 EAS
to the extent practicable, the provision of appro-
priate followup services and support services
such as case management;
‘‘(C) to establish mechanisms through which
State and local health departments can monitor
the quality of screening procedures for prostate
cancer, including the interpretation of such pro-
cedures; and
‘‘(D) to improve, in consultation with the
Health Resources and Services Administration,
the education, training, and skills of health prac-
titioners (including appropriate allied health
professionals) in the detection and control of
prostate cancer.
‘‘(8) To evaluate activities conducted under
paragraphs (1) through (7) through appropriate sur-
veillance or program monitoring activities.’’; and
(2) in subsection (l)(1), by striking ‘‘1998’’ and
inserting ‘‘2004’’.
(b) NATIONAL
INSTITUTES
OF
HEALTH.—Section
417B(c) of the Public Health Service Act (42 U.S.C. 286a–
8(c)) is amended by striking ‘‘and 1996’’ and inserting
‘‘through 2004’’.
HR 2498 EAS
TITLE VII—ORGAN
PROCUREMENT AND DONATION
SEC. 701. ORGAN PROCUREMENT ORGANIZATION CERTIFI-
CATION.
(a) SHORT TITLE.—This section may be cited as the
‘‘Organ Procurement Organization Certification Act of
2000’’.
(b) FINDINGS.—Congress makes the following findings:
(1) Organ procurement organizations play an
important role in the effort to increase organ dona-
tion in the United States.
(2) The current process for the certification and
recertification of organ procurement organizations
conducted by the Department of Health and Human
Services has created a level of uncertainty that is
interfering with the effectiveness of organ procurement
organizations in raising the level of organ donation.
(3) The General Accounting Office, the Institute
of Medicine, and the Harvard School of Public Health
have identified substantial limitations in the organ
procurement organization certification and recertifi-
cation process and have recommended changes in that
process.
(4) The limitations in the recertification process
include:
HR 2498 EAS
(A) An exclusive reliance on population-
based measures of performance that do not ac-
count for the potential in the population for
organ donation and do not permit consideration
of other outcome and process standards that
would more accurately reflect the relative capa-
bility and performance of each organ procure-
ment organization.
(B) A lack of due process to appeal to the
Secretary of Health and Human Services for re-
certification on either substantive or procedural
grounds.
(5) The Secretary of Health and Human Serv-
ices has the authority under section 1138(b)(1)(A)(i)
of the Social Security Act (42 U.S.C. 1320b–
8(b)(1)(A)(i)) to extend the period for recertification
of an organ procurement organization from 2 to 4
years on the basis of its past practices in order to
avoid the inappropriate disruption of the nation’s
organ system.
(6) The Secretary of Health and Human Serv-
ices can use the extended period described in para-
graph (5) for recertification of all organ procurement
organizations to—
HR 2498 EAS
(A) develop improved performance measures
that would reflect organ donor potential and in-
terim outcomes, and to test these measures to en-
sure that they accurately measure performance
differences among the organ procurement organi-
zations; and
(B) improve the overall certification process
by incorporating process as well as outcome per-
formance measures, and developing equitable
processes for appeals.
(c) CERTIFICATION AND RECERTIFICATION OF ORGAN
PROCUREMENT ORGANIZATIONS.—Section 371(b)(1) of the
Public Health Service Act (42 U.S.C. 273(b)(1)) is
amended—
(1) by redesignating subparagraphs (D) through
(G) as subparagraphs (E) through (H), respectively;
(2) by realigning the margin of subparagraph
(F) (as so redesignated) so as to align with subpara-
graph (E) (as so redesignated); and
(3) by inserting after subparagraph (C) the fol-
lowing:
‘‘(D) notwithstanding any other provision of
law, has met the other requirements of this section
and has been certified or recertified by the Secretary
within the previous 4-year period as meeting the per-
HR 2498 EAS
formance standards to be a qualified organ procure-
ment organization through a process that either—
‘‘(i) granted certification or recertification
within such 4-year period with such certification
or recertification in effect as of January 1, 2000,
and remaining in effect through the earlier of—
‘‘(I) January 1, 2002; or
‘‘(II) the completion of recertification
under the requirements of clause (ii); or
‘‘(ii) is defined through regulations that are
promulgated by the Secretary by not later than
January 1, 2002, that—
‘‘(I) require recertifications of qualified
organ procurement organizations not more
frequently than once every 4 years;
‘‘(II) rely on outcome and process per-
formance measures that are based on empir-
ical evidence, obtained through reasonable
efforts, of organ donor potential and other
related factors in each service area of quali-
fied organ procurement organizations;
‘‘(III) use multiple outcome measures
as part of the certification process; and
‘‘(IV) provide for a qualified organ
procurement organization to appeal a decer-
HR 2498 EAS
tification to the Secretary on substantive
and procedural grounds;’’.
SEC. 702. DESIGNATION OF GIVE THANKS, GIVE LIFE DAY.
(a) FINDINGS.—Congress finds that—
(1) traditionally, Thanksgiving is a time for
families to take time out of their busy lives to come
together and to give thanks for the many blessings in
their lives;
(2) approximately 21,000 men, women, and chil-
dren in the United States are given the gift of life
each year through transplantation surgery, made pos-
sible by the generosity of organ and tissue donations;
(3) more than 66,000 Americans are awaiting
their chance to prolong their lives by finding a
matching donor;
(4) nearly 5,000 of these patients each year (or
13 patients each day) die while waiting for a donated
heart, liver, kidney, or other organ;
(5) nationwide there are up to 15,000 potential
donors annually, but families’ consent to donation is
received for less than 6,000;
(6) the need for organ donations greatly exceeds
the supply available;
HR 2498 EAS
(7) designation as an organ donor on a driver’s
license or voter’s registration is a valuable step, but
does not ensure donation when an occasion arises;
(8) the demand for transplantation will likely
increase in the coming years due to the growing safe-
ty of transplantation surgery due to improvements in
technology and drug developments, prolonged life ex-
pectancy, and increased prevalence of diseases that
may lead to organ damage and failure, including hy-
pertension, alcoholism, and hepatitis C infection;
(9) the need for a more diverse donor pool, in-
cluding a variety of racial and ethnic minorities, will
continue to grow in the coming years;
(10) the final decision on whether a potential
donor can share the gift of life usually is made by
surviving family members regardless of the patient’s
initial intent;
(11) many Americans have indicated a willing-
ness to donate their organs and tissues but have not
discussed this critical matter with the family mem-
bers who are most likely to make the decision, if the
occasion arises, as to whether that person will be an
organ and tissue donor;
(12) some family members may be reluctant to
give consent to donate their deceased loved one’s or-
HR 2498 EAS
gans and tissues at a very difficult and emotional
time if that person has not clearly expressed a desire
or willingness to do so;
(13) the vast majority of Americans are likely to
spend part of Thanksgiving Day with some of those
family members who would be approached to make
such a decision; and
(14) it is fitting for families to spend a portion
of that day discussing how they might give life to oth-
ers on a day devoted to giving thanks for their own
blessings.
(b) DESIGNATION.—November 23, 2000, Thanksgiving
Day, is hereby designated as a day to ‘‘Give Thanks, Give
Life’’ and to discuss organ and tissue donation with other
family members so that informed decisions can be made if
the occasion to donate arises.
TITLE VIII—ALZHEIMER’S CLIN-
ICAL RESEARCH AND TRAIN-
ING
SEC. 801. ALZHEIMER’S CLINICAL RESEARCH AND TRAIN-
ING AWARDS.
Subpart 5 of part C of title IV of the Public Health
Service Act (42 U.S.C. 285e et seq.) is amended—
(1) by redesignating section 445I as section
445J; and
HR 2498 EAS
(2) by inserting after section 445H the following:
‘‘SEC. 445I. ALZHEIMER’S CLINICAL RESEARCH AND TRAIN-
ING AWARDS.
‘‘(a) IN GENERAL.—The Director of the Institute is au-
thorized to establish and maintain a program to enhance
and promote the translation of new scientific knowledge
into clinical practice related to the diagnosis, care and
treatment of individuals with Alzheimer’s disease.
‘‘(b) SUPPORT OF PROMISING CLINICIANS.—In order
to foster the application of the most current developments
in the etiology, pathogenesis, diagnosis, prevention and
treatment of Alzheimer’s disease, amounts made available
under this section shall be directed to the support of prom-
ising clinicians through awards for research, study, and
practice at centers of excellence in Alzheimer’s disease re-
search and treatment.
‘‘(c) EXCELLENCE
IN CERTAIN FIELDS.—Research
shall be carried out under awards made under subsection
(b) in environments of demonstrated excellence in neuro-
science, neurobiology, geriatric medicine, and psychiatry
and shall foster innovation and integration of such dis-
ciplines or other environments determined suitable by the
Director of the Institute.
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the
purpose of carrying out this section, there are authorized
HR 2498 EAS
to be appropriated $2,250,000 for fiscal year 2001, and
such sums as may be necessary for each of fiscal years 2002
through 2005.’’.
TITLE 
IX—SEXUALLY 
TRANS-
MITTED 
DISEASE 
CLINICAL
RESEARCH AND TRAINING
SEC. 901. SEXUALLY TRANSMITTED DISEASE CLINICAL RE-
SEARCH AND TRAINING AWARDS.
Subpart 6 of part C of title IV of the Public Health
Service Act (42 U.S.C. 285f et seq.) is amended by adding
at the end the following:
‘‘SEC. 447B. SEXUALLY TRANSMITTED DISEASE CLINICAL
RESEARCH AND TRAINING AWARDS.
‘‘(a) IN GENERAL.—The Director of the Institute is au-
thorized to establish and maintain a program to enhance
and promote the translation of new scientific knowledge
into clinical practice related to the diagnosis, care and
treatment of individuals with sexually transmitted diseases.
‘‘(b) SUPPORT OF PROMISING CLINICIANS.—In order
to foster the application of the most current developments
in the etiology, pathogenesis, diagnosis, prevention and
treatment of sexually transmitted diseases, amounts made
available under this section shall be directed to the support
of promising clinicians through awards for research, study,
HR 2498 EAS
and practice at centers of excellence in sexually transmitted
disease research and treatment.
‘‘(c) EXCELLENCE
IN CERTAIN FIELDS.—Research
shall be carried out under awards made under subsection
(b) in environments of demonstrated excellence in the eti-
ology and pathogenesis of sexually transmitted diseases and
shall foster innovation and integration of such disciplines
or other environments determined suitable by the Director
of the Institute.
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the
purpose of carrying out this section, there are authorized
to be appropriated $2,250,000 for fiscal year 2001, and
such sums as may be necessary for each of fiscal years 2002
through 2005.’’.
TITLE X—MISCELLANEOUS
PROVISION
SEC. 1001. TECHNICAL CORRECTION TO THE CHILDREN’S
HEALTH ACT OF 2000.
(a) IN GENERAL.—Section 2701 of the Children’s
Health Act of 2000 is amended by striking ‘‘part 45 of title
46’’ and inserting ‘‘part 46 of title 45’’.
HR 2498 EAS——2
HR 2498 EAS——3
HR 2498 EAS——4
HR 2498 EAS——5
HR 2498 EAS——6
HR 2498 EAS——7
HR 2498 EAS——8
HR 2498 EAS——9
HR 2498 EAS——10